Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Ovid Therapeutics Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 81 | 4 | 84 | +7 |
| Shares | 36.2M | 7.64M | 61.8M | +33.2M (+116.2%) |
| Value | $47.1M | $9.93M | $100.2M | +$63.0M (+169.7%) |
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 10,714,000 | $17.5M | 0.18% |
| Eventide Asset Management, LLC | 4,285,000 | $6.98M | 0.11% |
| Point72 Asset Management, L.P. | 3,551,129 | $5.79M | 0.01% |
| Federated Hermes, Inc. | 3,571,000 | $5.31M | 0.01% |
| Saturn V Capital Management LLC | 2,500,000 | $4.08M | 0.75% |
| Ally Bridge Group (NY) LLC | 1,785,000 | $2.91M | 4.62% |
| AWM Investment Company, Inc. | 899,200 | $1.47M | 0.14% |
| Graham Capital Management, L.P. | 127,459 | $207.8K | 0.01% |
| Omers Administration Corp | 125,300 | $204.2K | 0.00% |
| Stonepine Capital Management, LLC | 102,367 | $166.9K | 0.13% |
| Invesco Ltd. | 33,308 | $54.3K | 0.00% |
| Total Clarity Wealth Management, Inc. | 28,600 | $46.6K | 0.01% |
| Benin Management CORP | 19,000 | $31.0K | 0.01% |
| Nine Masts Capital Ltd | 13,960 | $22.8K | 0.00% |
| Sepio Capital, LP | 10,145 | $16.5K | 0.00% |
| Rockefeller Capital Management L.P. | 4,000 | $6.52K | 0.00% |
| Clearstead Advisors, LLC | 2,734 | $4.46K | 0.00% |
| TFC Financial Management | 1,000 | $1.63K | 0.00% |
| Tradewinds Capital Management, LLC | 100 | $163 | 0.00% |
| SageView Advisory Group, LLC | 44 | $72 | 0.00% |
Sold out (13)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Driehaus Capital Management LLC | 1,400,191 | $1.82M |
| Kennedy Capital Management, Inc. | 1,106,638 | $1.44M |
| Group One Trading, L.P. | 188,295 | $244.8K |
| Diadema Partners LP | 187,739 | $244.1K |
| Empowered Funds, LLC | 91,234 | $118.6K |
| Integrated Wealth Concepts LLC | 52,900 | $68.8K |
| Persistent Asset Partners Ltd | 46,040 | $59.9K |
| Apollon Wealth Management, LLC | 27,500 | $35.8K |
| Private Advisor Group, LLC | 25,600 | $33.3K |
| Two Sigma Securities, LLC | 11,698 | $15.2K |
| Advisory Services Network, LLC | 219 | $285 |
| Advisor Group Holdings, Inc. | 5 | $6 |
| CWM, LLC | 23 | $0 |
Not filed for Q4 2025 yet (4)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Takeda Pharmaceutical Co Ltd | 7,531,996 | $9.79M |
| Cubist Systematic Strategies, LLC | 86,652 | $112.6K |
| Point72 Asia (Singapore) Pte. Ltd. | 19,173 | $24.9K |
| Point72 (DIFC) Ltd | 197 | $256 |